Abstract: The present invention relates to novel compounds of formula (I) which are inhibitors of KRASNODAR interaction, their pharmaceutic ally acceptable esters, salts, solvates, isomers thereof. The present invention specifically relates to novel compounds of formula (I) or a pharmaceutically acceptable salt or a pharmaceutically acceptable regioisomer thereof and processes for their preparation.
The present invention specifically relates to novel compounds of formula (I) or a pharmaceutically acceptable salt or a pharmaceutically acceptable regioisomer thereof and processes for their preparation.
| # | Name | Date |
|---|---|---|
| 1 | 202447021520-STATEMENT OF UNDERTAKING (FORM 3) [21-03-2024(online)].pdf | 2024-03-21 |
| 2 | 202447021520-PRIORITY DOCUMENTS [21-03-2024(online)].pdf | 2024-03-21 |
| 3 | 202447021520-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [21-03-2024(online)].pdf | 2024-03-21 |
| 4 | 202447021520-FORM FOR SMALL ENTITY(FORM-28) [21-03-2024(online)].pdf | 2024-03-21 |
| 5 | 202447021520-FORM 1 [21-03-2024(online)].pdf | 2024-03-21 |
| 6 | 202447021520-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [21-03-2024(online)].pdf | 2024-03-21 |
| 7 | 202447021520-DECLARATION OF INVENTORSHIP (FORM 5) [21-03-2024(online)].pdf | 2024-03-21 |
| 8 | 202447021520-COMPLETE SPECIFICATION [21-03-2024(online)].pdf | 2024-03-21 |
| 9 | 202447021520-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [21-03-2024(online)].pdf | 2024-03-21 |
| 10 | 202447021520-Proof of Right [12-04-2024(online)].pdf | 2024-04-12 |
| 11 | 202447021520-FORM 18 [15-05-2024(online)].pdf | 2024-05-15 |
| 12 | 202447021520-FORM 3 [16-05-2024(online)].pdf | 2024-05-16 |